BioXcel Therapeutics Inc (BTAI)
2.57
+0.01
(+0.39%)
USD |
NASDAQ |
May 03, 16:00
2.57
0.00 (0.00%)
After-Hours: 20:00
BioXcel Therapeutics Accounts Receivable (Quarterly): 0.071M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.071M |
| September 30, 2023 | 0.735M |
| June 30, 2023 | 0.431M |
| March 31, 2023 | 0.283M |
| December 31, 2022 | 0.248M |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
0.735M
Maximum
Sep 2023
0.2947M
Average
0.2655M
Median
Accounts Receivable (Quarterly) Benchmarks
| Synlogic Inc | -- |
| Cormedix Inc | -- |
| Bristol-Myers Squibb Co | 8.826B |
| Verastem Inc | 0.00 |
| Ocular Therapeutix Inc | 26.18M |